Synlogic Inc (SYBX)
1.84
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
1.88
+0.04
(+2.17%)
Pre-Market: 20:00
Synlogic Revenue (Quarterly): 2.769M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.769M |
September 30, 2023 | 0.393M |
June 30, 2023 | 0.035M |
March 31, 2023 | 0.174M |
December 31, 2022 | 0.106M |
September 30, 2022 | 0.678M |
June 30, 2022 | 0.152M |
March 31, 2022 | 0.244M |
December 31, 2021 | 0.592M |
September 30, 2021 | 0.916M |
June 30, 2021 | 0.246M |
March 31, 2021 | |
December 31, 2020 |
Date | Value |
---|---|
September 30, 2020 | |
June 30, 2020 | 0.445M |
March 31, 2020 | 0.10M |
December 31, 2019 | 1.231M |
September 30, 2019 | 0.305M |
June 30, 2019 | 0.35M |
March 31, 2019 | 0.338M |
December 31, 2018 | 0.111M |
September 30, 2018 | 1.801M |
June 30, 2018 | 0.254M |
March 31, 2018 | 0.354M |
December 31, 2017 | 0.111M |
September 30, 2017 | 0.111M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.035M
Minimum
Jun 2023
2.769M
Maximum
Dec 2023
0.546M
Average
0.3275M
Median
Revenue (Quarterly) Benchmarks
BioXcel Therapeutics Inc | 0.376M |
Inotiv Inc | 135.50M |
IGM Biosciences Inc | 0.651M |
Humacyte Inc | -- |
Moderna Inc | 167.00M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -14.53M |
Total Expenses (Quarterly) | 13.41M |
EPS Diluted (Quarterly) | -1.582 |
Enterprise Value | -26.32M |
Profit Margin (Quarterly) | -524.9% |
Earnings Yield | -584.4% |
Normalized Earnings Yield | -584.36 |